Mavrilimumab May Aid Severe COVID-19 Recovery Mavrilimumab May Aid Severe COVID-19 Recovery

The granulocyte/macrophage-colony stimulating factor (GM-CSF) blocker reduced the need for mechanical ventilation and death by day 29 vs placebo.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news